New Triple-Threat attack on deadly prostate cancer
NCT ID NCT06499870
Summary
This study is testing whether combining two hormone-blocking drugs with radiation therapy works better than standard treatments for men with very high-risk prostate cancer. The goal is to more aggressively control the cancer and prevent it from returning. Researchers will follow 50 participants for up to four years to see if the cancer cells are eliminated and monitor side effects and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University
RECRUITINGChicago, Illinois, 60611, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.